Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients

Open access
Truxova, Iva, Kasikova, Lenka, Hensler, Michal, Skapa, Petr, Laco, Jan, Pecen, Ladislav, Belicova, Lucie, Praznovec, Ivan, Halaska, Michael J., Brtnicky, Tomas, Salkova, Eva, Rob, Lukas, Kodet, Roman, Goc, Jeremy, Sautes-Fridman, Catherine, Fridman, Wolf Herman, Ryska, Ales, Galluzzi, Lorenzo, Spisek, Radek, Fucikova, Jitka · 2018 · Journal for ImmunoTherapy of Cancer

Abstract

A high density of tumor-infiltrating CD8+ T cells and CD20+ B cells correlates with prolonged survival in patients with a wide variety of human cancers, including high-grade serous ovarian carcinoma (HGSC). However, the potential impact of mature dendritic cells (DCs) in shaping the immune contexture of HGSC, their role in the establishment of T cell-dependent antitumor immunity, and their potential prognostic value for HGSC patients remain unclear. We harnessed immunohistochemical tests and biomolecular analyses to demonstrate that a high density of tumor-infiltrating DC-LAMP+ DCs is robustly associated with an immune contexture characterized by TH1 polarization and cytotoxic activity. We showed that both mature DCs and CD20+ B cells play a critical role in the generation of a clinically-favorable cytotoxic immune response in HGSC microenvironment. In line with this notion, robust tumor infiltration by both DC-LAMP+ DCs and CD20+ B cells was associated with most favorable overall survival in two independent cohorts of chemotherapy-naïve HGSC patients. Our findings suggest that the presence of mature, DC-LAMP+ DCs in the tumor microenvironment may represent a novel, powerful prognostic biomarker for HGSC patients that reflects the activation of clinically-relevant anticancer immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40425-018-0446-3

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 191

Metadata

Authors
Truxova, I., Kasikova, L., Hensler, M., Skapa, P., Laco, J., Pecen, L., Belicova, L., Praznovec, I., Halaska, M. J., Brtnicky, T., Salkova, E., Rob, L., Kodet, R., Goc, J., Sautes-Fridman, C., Fridman, W. H., Ryska, A., Galluzzi, L., Spisek, R., & Fucikova, J.
Venue
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Published
2018-12
Volume
6
Issue
1
Pages
139-139
ISSN
2051-1426 (ISSN-L)
OpenAlex
W2902038187
Cited by
191
References
7
FWCI
14.15
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. https://app.cochat.ai/papers/10.1186/s40425-018-0446-3
The paper
Truxova, I., Kasikova, L., Hensler, M., Skapa, P., Laco, J., Pecen, L., Belicova, L., Praznovec, I., Halaska, M. J., Brtnicky, T., Salkova, E., Rob, L., Kodet, R., Goc, J., Sautes-Fridman, C., Fridman, W. H., Ryska, A., Galluzzi, L., Spisek, R., & Fucikova, J. (2018). Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1186/s40425-018-0446-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.